Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:12 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 15,665,210 7.52% | 5,607,847 (+55.76%) | View |
| 2024-02-12 12:21 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 23,076,052 11.08% | 2,421,765 (+11.73%) | View |
| 2024-02-09 09:49 am Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | FMR LLC | 10,897,286 5.231% | 10,897,286 (New Position) | View |
| 2024-01-29 5:25 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 12,393,872 6% | 1,726,248 (+16.18%) | View |
| 2024-01-29 4:00 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 20,654,287 9.92% | 20,654,287 (New Position) | View |
| 2024-01-26 10:49 am Sale | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 24,179,504 11.61% | -641,346 (-2.58%) | View |
| 2024-01-24 10:13 am Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | STATE STREET CORP STT | 12,151,646 5.83% | 12,151,646 (New Position) | View |
| 2023-05-22 4:05 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | Kinnevik AB (publ) | 10,405,668 5.6% | 10,405,668 (New Position) | View |
| 2023-02-14 4:05 pm Sale | 13G | RECURSION PHARMACEUTICALS INC RXRX | Lux Capital Management LLC | 6,004,722 3.3% | -7,016,797 (-53.89%) | View |
| 2023-02-09 11:30 am Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 10,057,363 5.54% | 10,057,363 (New Position) | View |
| 2023-02-03 12:10 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock Inc. BLK | 10,667,624 5.9% | 10,667,624 (New Position) | View |
| 2023-01-24 07:35 am Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 24,820,850 13.66% | 2,697,695 (+12.19%) | View |
| 2022-10-31 4:08 pm Purchase | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 11,291,937 6.3% | 2,551,020 (+29.18%) | View |
| 2022-02-14 4:16 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | Lux Capital Management LLC | 13,021,519 8.2% | 13,021,519 (New Position) | View |
| 2022-02-14 3:23 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | Data Collective IV L.P. | 13,619,224 8.5% | 13,619,224 (New Position) | View |
| 2022-01-27 10:18 am Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 22,123,155 13.87% | 5,104,498 (+29.99%) | View |
| 2021-11-04 5:27 pm Unchanged | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 8,740,917 5.5% | 0 (Unchanged) | View |
| 2021-05-06 12:01 pm Purchase | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 17,018,657 10.89% | 17,018,657 (New Position) | View |
| 2021-04-26 4:34 pm Purchase | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 8,740,917 5.7% | 8,740,917 (New Position) | View |